Physicochemical and functional comparability between the proposed biosimilar rituximab GP2013 and originator rituximab.

BioDrugs · 2013 · PMC3775154 · PMID 23649935

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The corresponding p values were all highly significant (<0.0001) confirming bioequivalence between GP2013 and the reference product.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.